![Viktor Roschke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Viktor Roschke
Directeur Technique/Scientifique/R&D chez
D&D PHARMATECH INC.
Fortune : 30 M $ au 31/05/2026
Profil
Viktor Roschke is the founder of Neuraly, Inc. since 2016, holding the title of Director & Chief Scientific Officer.
Current jobs include Secretary & Director at Theraly Fibrosis, Inc. and Chief Scientific Officer at D&D Pharmatech Co., Ltd. Former jobs include Executive Director-Cell Biology at Human Genome Sciences, Inc. from 2005, VP-Biopharmaceutical Research & Assay Development at Zyngenia, Inc., and Chief Operating Officer at Teva Biopharmaceuticals USA, Inc. Education includes a doctorate from Novosibirsk State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2025 | 482 036 ( 1,1 % ) | 30 M $ | 31/05/2026 |
Postes actifs de Viktor Roschke
| Sociétés | Poste | Début |
|---|---|---|
| D&D PHARMATECH INC. | Directeur Technique/Scientifique/R&D | - |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Directeur/Membre du Conseil | - |
Neuraly, Inc.
 Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Fondateur | 01/01/2016 |
Anciens postes connus de Viktor Roschke
| Sociétés | Poste | Fin |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 01/01/2005 |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Directeur des opérations | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Directeur Technique/Scientifique/R&D | - |
Formation de Viktor Roschke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Novosibirsk State University
 Novosibirsk State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
 D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
